Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali

The rapid diagnostic tests used in most resource-limited countries offer little specificity in the differentiation of HIV-1, HIV-2, and HIV-1 + 2. World Health Organization (WHO) does periodically evaluate rapid tests in use in the South Countries. Despite the prequalification from WHO, it is necess...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS research and human retroviruses 2019-02, Vol.35 (2), p.145-149
Hauptverfasser: Togo, Josue, Maiga, Almoustapha Issiaka, Sylla, Mariam, Kone, Bourahima, Dolo, Oumar, Traore, Fatoumata Tata, Sangare, Samba Adama, Maiga, Mamoudou, Diallo, Souleymane, Murphy, Robert, Calvez, Vincent, Marcelin, Anne-Genevieve
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 149
container_issue 2
container_start_page 145
container_title AIDS research and human retroviruses
container_volume 35
creator Togo, Josue
Maiga, Almoustapha Issiaka
Sylla, Mariam
Kone, Bourahima
Dolo, Oumar
Traore, Fatoumata Tata
Sangare, Samba Adama
Maiga, Mamoudou
Diallo, Souleymane
Murphy, Robert
Calvez, Vincent
Marcelin, Anne-Genevieve
description The rapid diagnostic tests used in most resource-limited countries offer little specificity in the differentiation of HIV-1, HIV-2, and HIV-1 + 2. World Health Organization (WHO) does periodically evaluate rapid tests in use in the South Countries. Despite the prequalification from WHO, it is necessary at local level to conduct comparative studies between the available tests. To do this in Mali, we conducted a cross-sectional study at the University Teaching Hospital Gabriel Touré and the Research and Training Center (SEREFO) of Bamako on 172 samples from retrospective and prospective studies. The goal of this project was to compare the following rapid tests: "HIV TRI-DOT" and OnSite HIV1/2 Ab Plus Combo Rapid Test for screening HIV-1 and HIV-2 to "ImmunoComb II BiSpot" (gold standard). The sensibility and specificity of "HIV TRI-DOT" for HIV-1 detection were 100% each [95% confidence interval (CI): 87.13-100 and 95.31-100]. Its performance for HIV-2 detection was 95.24% (95% CI: 84.21-98.68) (sensibility) and 100% (95% CI: 72.25-100) (specificity). The positive and negative predictive values were, respectively, 100% (95% CI: 91.24-100) and 83.33% (95% CI: 55.20-95.30). The sensibility and specificity of OnSite HIV1/2 Ab Plus Combo Rapid Test assay performance were 100% (95% CI: 87.13-100 and 95.31-100). Overall, OnSite HIV ½ Ab Combo Rapid Test proved to be a good test for warm countries and does not require refrigeration in these settings. Blood and its products can be used to perform the test, unlike "ImmunoComb II BiSpot" and "HIV TRI-DOT," which must be kept cold and cannot be done with whole blood.
doi_str_mv 10.1089/aid.2017.0296
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6422007</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2158239987</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-9fca9241bc0408809bac9afd80f6b10ee836b6e88302f1ffaf995deacefb5ac73</originalsourceid><addsrcrecordid>eNpdkUFP3DAQhS3UCra0R67IUg_0kmVsJ1n7UgktFJBASGXp1Zo4NjXK2kucbMu_bywoKj3NYT49vaePkAMGcwZSHaNv5xzYYg5c1TtkxpRghSyhekdmIKUqOOdqj3xI6QEAFOfVLtkTUNVQL-SM6LMtdiMOPgYaHV39ivTi8gf9jhvf0lOP9yGmwRu6smlI1AeKdBnDYH8PGb8devQhHdFzG2zGTv3W9skPTxm9xs5_JO8ddsl-ern75O7b2Wp5UVzdnF8uT64KU7JqKJQzqHjJGgPl1BpUg0ahayW4umFgrRR1U1spBXDHnEOnVNVaNNY1FZqF2Cdfn3M3Y7O2rbFhqtbpTe_X2D_piF6__QT_U9_Hra5LzgFywJeXgD4-jtNavfbJ2K7DYOOYNGeV5EIpmdHP_6EPcezDNE9zLkpgQvFMFc-U6WNKvXWvZRjorE5P6nRWp7O6iT_8d8Er_deV-AOZHJVm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2234013927</pqid></control><display><type>article</type><title>Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Togo, Josue ; Maiga, Almoustapha Issiaka ; Sylla, Mariam ; Kone, Bourahima ; Dolo, Oumar ; Traore, Fatoumata Tata ; Sangare, Samba Adama ; Maiga, Mamoudou ; Diallo, Souleymane ; Murphy, Robert ; Calvez, Vincent ; Marcelin, Anne-Genevieve</creator><creatorcontrib>Togo, Josue ; Maiga, Almoustapha Issiaka ; Sylla, Mariam ; Kone, Bourahima ; Dolo, Oumar ; Traore, Fatoumata Tata ; Sangare, Samba Adama ; Maiga, Mamoudou ; Diallo, Souleymane ; Murphy, Robert ; Calvez, Vincent ; Marcelin, Anne-Genevieve</creatorcontrib><description>The rapid diagnostic tests used in most resource-limited countries offer little specificity in the differentiation of HIV-1, HIV-2, and HIV-1 + 2. World Health Organization (WHO) does periodically evaluate rapid tests in use in the South Countries. Despite the prequalification from WHO, it is necessary at local level to conduct comparative studies between the available tests. To do this in Mali, we conducted a cross-sectional study at the University Teaching Hospital Gabriel Touré and the Research and Training Center (SEREFO) of Bamako on 172 samples from retrospective and prospective studies. The goal of this project was to compare the following rapid tests: "HIV TRI-DOT" and OnSite HIV1/2 Ab Plus Combo Rapid Test for screening HIV-1 and HIV-2 to "ImmunoComb II BiSpot" (gold standard). The sensibility and specificity of "HIV TRI-DOT" for HIV-1 detection were 100% each [95% confidence interval (CI): 87.13-100 and 95.31-100]. Its performance for HIV-2 detection was 95.24% (95% CI: 84.21-98.68) (sensibility) and 100% (95% CI: 72.25-100) (specificity). The positive and negative predictive values were, respectively, 100% (95% CI: 91.24-100) and 83.33% (95% CI: 55.20-95.30). The sensibility and specificity of OnSite HIV1/2 Ab Plus Combo Rapid Test assay performance were 100% (95% CI: 87.13-100 and 95.31-100). Overall, OnSite HIV ½ Ab Combo Rapid Test proved to be a good test for warm countries and does not require refrigeration in these settings. Blood and its products can be used to perform the test, unlike "ImmunoComb II BiSpot" and "HIV TRI-DOT," which must be kept cold and cannot be done with whole blood.</description><identifier>ISSN: 0889-2229</identifier><identifier>EISSN: 1931-8405</identifier><identifier>DOI: 10.1089/aid.2017.0296</identifier><identifier>PMID: 30560678</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Adolescent ; Adult ; AIDS/HIV ; Blood ; Child ; Child, Preschool ; Comparative studies ; Confidence intervals ; Cross-Sectional Studies ; Diagnostic systems ; Diagnostic tests ; Epidemiology ; Female ; Genetic diversity ; Genetic Variation ; HIV ; HIV Antibodies - blood ; HIV Infections - diagnosis ; HIV Infections - virology ; HIV-1 - genetics ; HIV-1 - immunology ; HIV-2 - genetics ; HIV-2 - immunology ; Human immunodeficiency virus ; Humans ; Male ; Mali ; Middle Aged ; Onsite ; Predictive Value of Tests ; Reagent Kits, Diagnostic - standards ; Refrigeration ; Retrospective Studies ; Sensitivity and Specificity ; Serologic Tests - standards ; Young Adult</subject><ispartof>AIDS research and human retroviruses, 2019-02, Vol.35 (2), p.145-149</ispartof><rights>Copyright Mary Ann Liebert, Inc. Feb 2019</rights><rights>Copyright 2019, Mary Ann Liebert, Inc., publishers 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-9fca9241bc0408809bac9afd80f6b10ee836b6e88302f1ffaf995deacefb5ac73</citedby><cites>FETCH-LOGICAL-c415t-9fca9241bc0408809bac9afd80f6b10ee836b6e88302f1ffaf995deacefb5ac73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,782,786,887,27931,27932</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30560678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Togo, Josue</creatorcontrib><creatorcontrib>Maiga, Almoustapha Issiaka</creatorcontrib><creatorcontrib>Sylla, Mariam</creatorcontrib><creatorcontrib>Kone, Bourahima</creatorcontrib><creatorcontrib>Dolo, Oumar</creatorcontrib><creatorcontrib>Traore, Fatoumata Tata</creatorcontrib><creatorcontrib>Sangare, Samba Adama</creatorcontrib><creatorcontrib>Maiga, Mamoudou</creatorcontrib><creatorcontrib>Diallo, Souleymane</creatorcontrib><creatorcontrib>Murphy, Robert</creatorcontrib><creatorcontrib>Calvez, Vincent</creatorcontrib><creatorcontrib>Marcelin, Anne-Genevieve</creatorcontrib><title>Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali</title><title>AIDS research and human retroviruses</title><addtitle>AIDS Res Hum Retroviruses</addtitle><description>The rapid diagnostic tests used in most resource-limited countries offer little specificity in the differentiation of HIV-1, HIV-2, and HIV-1 + 2. World Health Organization (WHO) does periodically evaluate rapid tests in use in the South Countries. Despite the prequalification from WHO, it is necessary at local level to conduct comparative studies between the available tests. To do this in Mali, we conducted a cross-sectional study at the University Teaching Hospital Gabriel Touré and the Research and Training Center (SEREFO) of Bamako on 172 samples from retrospective and prospective studies. The goal of this project was to compare the following rapid tests: "HIV TRI-DOT" and OnSite HIV1/2 Ab Plus Combo Rapid Test for screening HIV-1 and HIV-2 to "ImmunoComb II BiSpot" (gold standard). The sensibility and specificity of "HIV TRI-DOT" for HIV-1 detection were 100% each [95% confidence interval (CI): 87.13-100 and 95.31-100]. Its performance for HIV-2 detection was 95.24% (95% CI: 84.21-98.68) (sensibility) and 100% (95% CI: 72.25-100) (specificity). The positive and negative predictive values were, respectively, 100% (95% CI: 91.24-100) and 83.33% (95% CI: 55.20-95.30). The sensibility and specificity of OnSite HIV1/2 Ab Plus Combo Rapid Test assay performance were 100% (95% CI: 87.13-100 and 95.31-100). Overall, OnSite HIV ½ Ab Combo Rapid Test proved to be a good test for warm countries and does not require refrigeration in these settings. Blood and its products can be used to perform the test, unlike "ImmunoComb II BiSpot" and "HIV TRI-DOT," which must be kept cold and cannot be done with whole blood.</description><subject>Adolescent</subject><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Blood</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Comparative studies</subject><subject>Confidence intervals</subject><subject>Cross-Sectional Studies</subject><subject>Diagnostic systems</subject><subject>Diagnostic tests</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Genetic diversity</subject><subject>Genetic Variation</subject><subject>HIV</subject><subject>HIV Antibodies - blood</subject><subject>HIV Infections - diagnosis</subject><subject>HIV Infections - virology</subject><subject>HIV-1 - genetics</subject><subject>HIV-1 - immunology</subject><subject>HIV-2 - genetics</subject><subject>HIV-2 - immunology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Male</subject><subject>Mali</subject><subject>Middle Aged</subject><subject>Onsite</subject><subject>Predictive Value of Tests</subject><subject>Reagent Kits, Diagnostic - standards</subject><subject>Refrigeration</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><subject>Serologic Tests - standards</subject><subject>Young Adult</subject><issn>0889-2229</issn><issn>1931-8405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUFP3DAQhS3UCra0R67IUg_0kmVsJ1n7UgktFJBASGXp1Zo4NjXK2kucbMu_bywoKj3NYT49vaePkAMGcwZSHaNv5xzYYg5c1TtkxpRghSyhekdmIKUqOOdqj3xI6QEAFOfVLtkTUNVQL-SM6LMtdiMOPgYaHV39ivTi8gf9jhvf0lOP9yGmwRu6smlI1AeKdBnDYH8PGb8devQhHdFzG2zGTv3W9skPTxm9xs5_JO8ddsl-ern75O7b2Wp5UVzdnF8uT64KU7JqKJQzqHjJGgPl1BpUg0ahayW4umFgrRR1U1spBXDHnEOnVNVaNNY1FZqF2Cdfn3M3Y7O2rbFhqtbpTe_X2D_piF6__QT_U9_Hra5LzgFywJeXgD4-jtNavfbJ2K7DYOOYNGeV5EIpmdHP_6EPcezDNE9zLkpgQvFMFc-U6WNKvXWvZRjorE5P6nRWp7O6iT_8d8Er_deV-AOZHJVm</recordid><startdate>20190201</startdate><enddate>20190201</enddate><creator>Togo, Josue</creator><creator>Maiga, Almoustapha Issiaka</creator><creator>Sylla, Mariam</creator><creator>Kone, Bourahima</creator><creator>Dolo, Oumar</creator><creator>Traore, Fatoumata Tata</creator><creator>Sangare, Samba Adama</creator><creator>Maiga, Mamoudou</creator><creator>Diallo, Souleymane</creator><creator>Murphy, Robert</creator><creator>Calvez, Vincent</creator><creator>Marcelin, Anne-Genevieve</creator><general>Mary Ann Liebert, Inc</general><general>Mary Ann Liebert, Inc., publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190201</creationdate><title>Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali</title><author>Togo, Josue ; Maiga, Almoustapha Issiaka ; Sylla, Mariam ; Kone, Bourahima ; Dolo, Oumar ; Traore, Fatoumata Tata ; Sangare, Samba Adama ; Maiga, Mamoudou ; Diallo, Souleymane ; Murphy, Robert ; Calvez, Vincent ; Marcelin, Anne-Genevieve</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-9fca9241bc0408809bac9afd80f6b10ee836b6e88302f1ffaf995deacefb5ac73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Blood</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Comparative studies</topic><topic>Confidence intervals</topic><topic>Cross-Sectional Studies</topic><topic>Diagnostic systems</topic><topic>Diagnostic tests</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Genetic diversity</topic><topic>Genetic Variation</topic><topic>HIV</topic><topic>HIV Antibodies - blood</topic><topic>HIV Infections - diagnosis</topic><topic>HIV Infections - virology</topic><topic>HIV-1 - genetics</topic><topic>HIV-1 - immunology</topic><topic>HIV-2 - genetics</topic><topic>HIV-2 - immunology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Male</topic><topic>Mali</topic><topic>Middle Aged</topic><topic>Onsite</topic><topic>Predictive Value of Tests</topic><topic>Reagent Kits, Diagnostic - standards</topic><topic>Refrigeration</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><topic>Serologic Tests - standards</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Togo, Josue</creatorcontrib><creatorcontrib>Maiga, Almoustapha Issiaka</creatorcontrib><creatorcontrib>Sylla, Mariam</creatorcontrib><creatorcontrib>Kone, Bourahima</creatorcontrib><creatorcontrib>Dolo, Oumar</creatorcontrib><creatorcontrib>Traore, Fatoumata Tata</creatorcontrib><creatorcontrib>Sangare, Samba Adama</creatorcontrib><creatorcontrib>Maiga, Mamoudou</creatorcontrib><creatorcontrib>Diallo, Souleymane</creatorcontrib><creatorcontrib>Murphy, Robert</creatorcontrib><creatorcontrib>Calvez, Vincent</creatorcontrib><creatorcontrib>Marcelin, Anne-Genevieve</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>AIDS research and human retroviruses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Togo, Josue</au><au>Maiga, Almoustapha Issiaka</au><au>Sylla, Mariam</au><au>Kone, Bourahima</au><au>Dolo, Oumar</au><au>Traore, Fatoumata Tata</au><au>Sangare, Samba Adama</au><au>Maiga, Mamoudou</au><au>Diallo, Souleymane</au><au>Murphy, Robert</au><au>Calvez, Vincent</au><au>Marcelin, Anne-Genevieve</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali</atitle><jtitle>AIDS research and human retroviruses</jtitle><addtitle>AIDS Res Hum Retroviruses</addtitle><date>2019-02-01</date><risdate>2019</risdate><volume>35</volume><issue>2</issue><spage>145</spage><epage>149</epage><pages>145-149</pages><issn>0889-2229</issn><eissn>1931-8405</eissn><abstract>The rapid diagnostic tests used in most resource-limited countries offer little specificity in the differentiation of HIV-1, HIV-2, and HIV-1 + 2. World Health Organization (WHO) does periodically evaluate rapid tests in use in the South Countries. Despite the prequalification from WHO, it is necessary at local level to conduct comparative studies between the available tests. To do this in Mali, we conducted a cross-sectional study at the University Teaching Hospital Gabriel Touré and the Research and Training Center (SEREFO) of Bamako on 172 samples from retrospective and prospective studies. The goal of this project was to compare the following rapid tests: "HIV TRI-DOT" and OnSite HIV1/2 Ab Plus Combo Rapid Test for screening HIV-1 and HIV-2 to "ImmunoComb II BiSpot" (gold standard). The sensibility and specificity of "HIV TRI-DOT" for HIV-1 detection were 100% each [95% confidence interval (CI): 87.13-100 and 95.31-100]. Its performance for HIV-2 detection was 95.24% (95% CI: 84.21-98.68) (sensibility) and 100% (95% CI: 72.25-100) (specificity). The positive and negative predictive values were, respectively, 100% (95% CI: 91.24-100) and 83.33% (95% CI: 55.20-95.30). The sensibility and specificity of OnSite HIV1/2 Ab Plus Combo Rapid Test assay performance were 100% (95% CI: 87.13-100 and 95.31-100). Overall, OnSite HIV ½ Ab Combo Rapid Test proved to be a good test for warm countries and does not require refrigeration in these settings. Blood and its products can be used to perform the test, unlike "ImmunoComb II BiSpot" and "HIV TRI-DOT," which must be kept cold and cannot be done with whole blood.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>30560678</pmid><doi>10.1089/aid.2017.0296</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0889-2229
ispartof AIDS research and human retroviruses, 2019-02, Vol.35 (2), p.145-149
issn 0889-2229
1931-8405
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6422007
source MEDLINE; Alma/SFX Local Collection
subjects Adolescent
Adult
AIDS/HIV
Blood
Child
Child, Preschool
Comparative studies
Confidence intervals
Cross-Sectional Studies
Diagnostic systems
Diagnostic tests
Epidemiology
Female
Genetic diversity
Genetic Variation
HIV
HIV Antibodies - blood
HIV Infections - diagnosis
HIV Infections - virology
HIV-1 - genetics
HIV-1 - immunology
HIV-2 - genetics
HIV-2 - immunology
Human immunodeficiency virus
Humans
Male
Mali
Middle Aged
Onsite
Predictive Value of Tests
Reagent Kits, Diagnostic - standards
Refrigeration
Retrospective Studies
Sensitivity and Specificity
Serologic Tests - standards
Young Adult
title Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T13%3A13%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20Two%20HIV%20Rapid%20Diagnostic%20Tests%20in%20a%20Context%20of%20Strains'%20Genetic%20Diversity%20in%20Mali&rft.jtitle=AIDS%20research%20and%20human%20retroviruses&rft.au=Togo,%20Josue&rft.date=2019-02-01&rft.volume=35&rft.issue=2&rft.spage=145&rft.epage=149&rft.pages=145-149&rft.issn=0889-2229&rft.eissn=1931-8405&rft_id=info:doi/10.1089/aid.2017.0296&rft_dat=%3Cproquest_pubme%3E2158239987%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2234013927&rft_id=info:pmid/30560678&rfr_iscdi=true